Anastasiia Priss

6PUBLICATIONS
10CO-AUTHORS
NanometrologyMolecular targetsNeurology and neuromuscular diseasesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2026
RNA Size and Structure Modulate the Apparent pKa of Ionizable Lipid Nanoparticles.

|May 24, 2024
Upregulation of mRNA Expression of ADGRD1/GPR133 and ADGRG7/GPR128 in SARS-CoV-2-Infected Lung Adenocarcinoma Calu-3 Cells.

Sandra Žáčková, Marcela Pávová, Jana Trylčová

|Nov 02, 2023
Navigating α-Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets.

Maksym Galkin, Anastasiia Priss, Yevhenii Kyriukha

|May 10, 2023
Dopamine-Induced Oligomers of α-Synuclein Inhibit Amyloid Fibril Growth and Show No Toxicity.

Maksym Galkin, Oleksandra Topcheva, Anastasiia Priss

|Oct 23, 2021
FRET-based assay for intracellular evaluation of α-synuclein aggregation inhibitors.

Maksym Galkin, Anastasiia Priss, Oleksandra Topcheva

|May 10, 2021
Rationally Designed Protein-Based Inhibitor of α-Synuclein Fibrillization in Cells.

Anastasiia Priss, Kseniia Afitska, Maksym Galkin

Pageof 1

Frequent Collaborators

4 joint publications

Maksym Galkin

4 joint publications

Volodymyr V Shvadchak

2 joint publications

Dmytro A Yushchenko

1 joint publications

Oleksandra Topcheva